Citi Starts Bellicum Pharmaceuticals (BLCM) at Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/18/2026
- Wall Street indexes slip as oil prices rise, retail results awaited
- Trump threatens to bomb Oman over Iran stance
- Why this Wall Street strategist says the "trade is long gold"
- U.S. EV market shows signs of bottoming out: Bernstein
- Micron rises as White House presses Apple to avoid Chinese memory chips
- Wall Street indexes slip as oil prices rise, retail results awaited
- Micron rises as White House presses Apple to avoid Chinese memory chips
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- Trump threatens to bomb Oman over Iran stance
- H.C. Wainwright Reiterates Buy Rating on Soluna (SLNH)
Bellicum Pharmaceuticals (BLCM) BPX-501 Moving Faster Than Many Realize, Piper Jaffray Says
July 28, 2015 8:40 AM EDTPiper Jaffray analyst Joshua Schimmer reiterated an Overweight rating and $45 price target on Bellicum Pharmaceuticals (NASDAQ: BLCM) saying BPX-501 is moving faster than many realize.
Schimmer commented, "As we pass the halfway mark of 2015, we are refreshing our outlooks for our coverage universe. For... More
